{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-04-28", "results": { "skip": 0, "limit": 1, "total": 42708 } }, "results": [ { "safetyreportversion": "4", "safetyreportid": "10028729", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20190204", "reporttype": "1", "serious": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20140321", "receiptdateformat": "102", "receiptdate": "20181220", "fulfillexpeditecriteria": "1", "companynumb": "US-TEVA-470236USA", "duplicate": "1", "reportduplicate": { "duplicatesource": "TEVA", "duplicatenumb": "US-TEVA-470236USA" }, "primarysource": { "reportercountry": "US", "qualification": "1" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "34", "patientonsetageunit": "801", "patientweight": "79.9", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "21.1", "reactionmeddrapt": "Drug ineffective", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.1", "reactionmeddrapt": "Maternal exposure during pregnancy", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.1", "reactionmeddrapt": "Pregnancy with contraceptive device", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.1", "reactionmeddrapt": "Device dislocation", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "PARAGARD T 380A", "drugauthorizationnumb": "018680", "drugadministrationroute": "015", "drugindication": "CONTRACEPTION", "drugstartdateformat": "102", "drugstartdate": "20070813", "actiondrug": "4", "activesubstance": { "activesubstancename": "COPPER" }, "openfda": { "application_number": [ "NDA018680" ], "brand_name": [ "PARAGARD T 380A" ], "generic_name": [ "COPPER" ], "manufacturer_name": [ "CooperSurgical, Inc." ], "product_ndc": [ "59365-5129", "59365-5128" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAUTERINE" ], "substance_name": [ "COPPER" ], "rxcui": [ "2267305", "2267310" ], "spl_id": [ "898e2915-26f8-44c3-a16f-e45ab2352d06", "226b4d58-044f-4016-9da3-6fd6a37645dd" ], "spl_set_id": [ "3c420b53-c95e-46af-aebd-73741be58391", "5ea7ce51-b87a-485e-b841-99466a07a4b2" ], "package_ndc": [ "59365-5129-1", "59365-5128-1" ], "nui": [ "M0005152", "N0000175831", "N0000008595", "N0000008924", "N0000175830" ], "pharm_class_cs": [ "Copper [CS]" ], "pharm_class_epc": [ "Copper-containing Intrauterine Device [EPC]" ], "pharm_class_pe": [ "Decreased Embryonic Implantation [PE]", "Decreased Sperm Motility [PE]", "Inhibit Ovum Fertilization [PE]" ], "unii": [ "789U1901C5" ] } }, { "drugcharacterization": "2", "medicinalproduct": "PHENTERMINE.", "drugindication": "WEIGHT DECREASED", "activesubstance": { "activesubstancename": "PHENTERMINE" }, "openfda": { "application_number": [ "ANDA204318" ], "brand_name": [ "PHENTERMINE" ], "generic_name": [ "PHENTERMINE HYDROCHLORIDE" ], "manufacturer_name": [ "Aurolife Pharma, LLC" ], "product_ndc": [ "13107-105", "13107-106" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "PHENTERMINE HYDROCHLORIDE" ], "rxcui": [ "900038", "968766" ], "spl_id": [ "53dd7857-41fb-4da1-88f7-5c68a509bfb0" ], "spl_set_id": [ "737eef3b-9a6b-4ab3-a25c-49d84d2a0197" ], "package_ndc": [ "13107-105-30", "13107-105-01", "13107-106-30", "13107-106-01" ], "unii": [ "0K2I505OTV" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CYTOMEL", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "LIOTHYRONINE SODIUM" }, "openfda": { "application_number": [ "NDA010379" ], "brand_name": [ "CYTOMEL" ], "generic_name": [ "LIOTHYRONINE SODIUM" ], "manufacturer_name": [ "Pfizer Laboratories Div Pfizer Inc" ], "product_ndc": [ "60793-115", "60793-116", "60793-117" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LIOTHYRONINE SODIUM" ], "spl_id": [ "5c1150d8-903d-4c39-aa66-5a095ee1b00a" ], "spl_set_id": [ "51452b31-ff68-4e0c-b982-c15502ebf1d3" ], "package_ndc": [ "60793-115-01", "60793-116-01", "60793-117-01" ], "unii": [ "GCA9VV7D2N" ] } }, { "drugcharacterization": "2", "medicinalproduct": "VYVANSE", "drugindication": "DEPRESSION", "activesubstance": { "activesubstancename": "LISDEXAMFETAMINE DIMESYLATE" }, "openfda": { "application_number": [ "NDA021977", "NDA208510" ], "brand_name": [ "VYVANSE" ], "generic_name": [ "LISDEXAMFETAMINE DIMESYLATE" ], "manufacturer_name": [ "Takeda Pharmaceuticals America, Inc." ], "product_ndc": [ "59417-101", "59417-102", "59417-103", "59417-104", "59417-105", "59417-106", "59417-107", "59417-115", "59417-116", "59417-117", "59417-118", "59417-119", "59417-120" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LISDEXAMFETAMINE DIMESYLATE" ], "rxcui": [ "854830", "854832", "854834", "854836", "854838", "854840", "854842", "854844", "854846", "854848", "854850", "854852", "1593856", "1593858", "1871456", "1871459", "1871460", "1871461", "1871462", "1871463", "1871464", "1871465", "1871466", "1871467", "1871468", "1871469" ], "spl_id": [ "81d087b6-4cb4-466a-9693-679edeb062e2" ], "spl_set_id": [ "704e4378-ca83-445c-8b45-3cfa51c1ecad" ], "package_ndc": [ "59417-101-10", "59417-102-10", "59417-103-10", "59417-104-10", "59417-105-10", "59417-106-10", "59417-107-10", "59417-115-01", "59417-116-01", "59417-117-01", "59417-118-01", "59417-119-01", "59417-120-01" ], "unii": [ "SJT761GEGS" ] } }, { "drugcharacterization": "2", "medicinalproduct": "SYNTHROID", "drugindication": "THYROID DISORDER", "activesubstance": { "activesubstancename": "LEVOTHYROXINE SODIUM" }, "openfda": { "application_number": [ "NDA021402" ], "brand_name": [ "SYNTHROID" ], "generic_name": [ "LEVOTHYROXINE SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LEVOTHYROXINE SODIUM" ], "rxcui": [ "892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282" ], "spl_id": [ "b85ab7fa-ba96-43cd-b736-44b3924e644c" ], "spl_set_id": [ "1e11ad30-1041-4520-10b0-8f9d30d30fcc" ], "package_ndc": [ "0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19" ], "unii": [ "9J765S329G" ] } } ], "summary": { "narrativeincludeclinical": "CASE EVENT DATE: 20140318" } } } ] }